Even as there is acute shortage for human albumin across the country,
Mumbai-based blood banks are providing the vital blood component called
plasma required to manufacture albumin on a sustainable basis.
Though Reliance Life Sciences is awaiting central government's approval on imports of plasma required for its production on a large scale, official sources inform that Reliance is currently supplying human albumin under its brand Albu Rel to limited hospitals based on the demand.
Plasma separated from whole blood is fractionated to produce many useful life-saving components such as Factor VIII, fibrinogen, albumin, and gamma globulin. India now imports every year fractionated components valued at more than Rs.50 crore.
According to stockists, human albumin is currently scarcely available with prices ranging between Rs.3897 and Rs.4092 respectively. Pharmaceutical companies like Reliance, Intas, Bharat Serums and Baxter were major manufacturers and suppliers of albumin in Indian markets. After slashing of prices by the NPPA, they have stopped supply to domestic markets.
The price of one ml albumin injection of 20 per cent has been capped up to Rs.36. 66 after being brought under Drug Price Control Order (DPCO) -2013 issued by the National Pharmaceutical Pricing Authority (NPPA). Albumin is an essential life-saving drug which should be priced reasonably, according to NPPA.
Though Reliance Life Sciences is awaiting central government's approval on imports of plasma required for its production on a large scale, official sources inform that Reliance is currently supplying human albumin under its brand Albu Rel to limited hospitals based on the demand.
Plasma separated from whole blood is fractionated to produce many useful life-saving components such as Factor VIII, fibrinogen, albumin, and gamma globulin. India now imports every year fractionated components valued at more than Rs.50 crore.
According to stockists, human albumin is currently scarcely available with prices ranging between Rs.3897 and Rs.4092 respectively. Pharmaceutical companies like Reliance, Intas, Bharat Serums and Baxter were major manufacturers and suppliers of albumin in Indian markets. After slashing of prices by the NPPA, they have stopped supply to domestic markets.
The price of one ml albumin injection of 20 per cent has been capped up to Rs.36. 66 after being brought under Drug Price Control Order (DPCO) -2013 issued by the National Pharmaceutical Pricing Authority (NPPA). Albumin is an essential life-saving drug which should be priced reasonably, according to NPPA.
No comments:
Post a Comment